Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Moderna Inc
(NQ:
MRNA
)
122.11
+1.71 (+1.42%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
99
100
Next >
Moderna Pops After FDA Grants Its Cancer Vaccine A Breakthrough Designation
February 22, 2023
The companies could see a speedier review process.
Via
Investor's Business Daily
Where Will Moderna Be in 5 Years?
February 21, 2023
Moderna shares have what it takes to gain over time.
Via
The Motley Fool
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
February 21, 2023
These stocks have something to offer every type of investor.
Via
The Motley Fool
2 Resilient Growth Stocks to Buy and Hold Forever
February 18, 2023
These two "pandemic stocks" are still great investments.
Via
The Motley Fool
Investors Fear Stock Markets Will Give Up 2023 Gains
February 17, 2023
Find out what's moving markets on Friday.
Via
The Motley Fool
Moderna Hypes 'Important Step' In Flu Shot Results, But Market Disagrees
February 17, 2023
Shares crumbled after Moderna's flu shot outperformed in just one flu strain.
Via
Investor's Business Daily
5 Value Stocks In The Healthcare Sector
February 13, 2023
Via
Benzinga
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 17, 2023
Gainers Ibio Inc (NYSE: IBIO) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program.
Via
Benzinga
Is the Stock Market Open on Presidents’ Day 2023?
February 17, 2023
Investors are wondering if the stock market is open on Presidents' Day 2023 as they make weekend plans and we have the answer.
Via
InvestorPlace
Why Is Moderna (MRNA) Stock Down 5% Today?
February 17, 2023
If Moderna's new formulation works the latest failure will be a short-term hiccup. But MRNA stock also faces legal and PR challenges.
Via
InvestorPlace
Why Moderna Shares Are Falling
February 17, 2023
Moderna Inc (NASDAQ: MRNA) shares are trading lower by 5.52% to $162.79 Friday morning after the company released interim Phase 3 safety and immunogenicity results for its mRNA-1010 influenza...
Via
Benzinga
Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents
February 17, 2023
Via
Benzinga
Moderna, Cognex, Stem And Other Big Stocks Moving Lower In Friday's Pre-Market Session
February 17, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. XP Inc (NASDAQ: XP) shares tumbled 13.1% to $13.82 in pre-market trading...
Via
Benzinga
Nasdaq, S&P 500 Futures Indicate Weak Opening For Wall Street: Benefit Of Lowering Recession Risk Comes With Sticky Inflation Threat, Says Economist
February 17, 2023
Index futures indicate U.S. markets are on track for a weak opening in continuation of Thursday's decline after hawkish comments from Federal Reserve officials and a higher than expected producers'...
Via
Benzinga
Tesla, DraftKings, DoorDash, Moderna, Stem: Why These Five Stocks Are Drawing Investors' Attention Today
February 16, 2023
Via
Benzinga
After-Hours Alert: Why Moderna Stock Is Diving
February 16, 2023
Moderna Inc (NASDAQ: MRNA) shares are trading lower in Thursday's after-hours session after the company released interim Phase 3 safety and immunogenicity
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 16, 2023
Via
Benzinga
A Bull Market Is Coming. To Prepare, Take Warren Buffett's Advice.
February 16, 2023
Quality and price are two key elements to keep in mind.
Via
The Motley Fool
Moderna's CEO To Appear Before Senate On Quadrupling COVID-19 Vaccine Prices
February 16, 2023
Moderna Inc's (NASDAQ: MRNA) CEO, Stéphane Bancel, will testify next month on its plans to raise the price of its COVID-19 vaccine in front of the Senate.
Via
Benzinga
7 Hot Healthcare Stocks With the Potential to Outperform
February 15, 2023
These healthcare stocks to buy now have the potential to outperform the market over the long-term because their businesses are strong.
Via
InvestorPlace
Is This the Telltale Sign to Sell Novavax Stock?
February 14, 2023
You won't find Novavax's latest bad news trumpeted in a press release.
Via
The Motley Fool
Candy? Flowers? These Top Stocks Offer You Something Even Sweeter
February 14, 2023
These stocks may reward you over time.
Via
The Motley Fool
Fox, MGM Resorts And 3 Other Stocks Insiders Are Selling
February 13, 2023
The Nasdaq closed lower on Friday, also recording losses for the week. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
These Cheap Growth Stocks Could Supercharge Your Portfolio
February 12, 2023
All of these players are cheap today considering their growth potential.
Via
The Motley Fool
Moderna Stock Getting Closer To Key Technical Benchmark
February 10, 2023
On Friday, biotech Moderna stock received an upgrade to its Relative Strength (RS) Rating, to 72 from 69 a day earlier.
Via
Investor's Business Daily
'I Think It's Peaked Already': Jim Cramer On This Stock Up 22% Over Past Month
February 10, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Okta Inc (NASDAQ: OKTA) CEO Todd McKinnon has "got to pivot first.
Via
Benzinga
Is Novavax Stock a Buy With the New Normal for COVID?
February 10, 2023
The landscape has shifted dramatically in the COVID-19 vaccine market.
Via
The Motley Fool
Analyst Upgrades Personalis; Says Biopharma Is Strong, Cash Burn Is Down
February 06, 2023
Via
Benzinga
1 Company Bucks the Office REIT Trend With Higher Rents and Earnings
February 06, 2023
Life sciences companies may be more immune to work-from-home shifts.
Via
The Motley Fool
Danaher Shows Interest In Acquiring Catalent Valued At Significant Premium: Report
February 06, 2023
Danaher Corporation (NYSE: DHR) has reportedly expressed interest in acquiring the contract manufacturer Catalent Inc (NYSE: CTLT).
Via
Benzinga
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.